Repeated exposure to Ochratoxin A generates a neuroinflammatory response, characterized by neurodegenerative M1

Jenny Sandström von Tobel1, Paola Antinori2, Marie-Gabrielle Zurich1

  • 1Swiss Centre for Applied Human Toxicology (SCAHT), Switzerland; Department of Physiology, University of Lausanne, CH-1005 Lausanne, Switzerland.

Neurotoxicology
|May 6, 2014
PubMed

Insights

The mycotoxin Ochratoxin A (OTA) causes neuroinflammation and demyelination in rat brain cells. Co-treatment with sonic hedgehog (SHH) and metallothioneins partially reversed these toxic effects, suggesting therapeutic potential.

Area of Science:

  • Neuroscience
  • Toxicology
  • Cell Biology

Background:

  • Ochratoxin A (OTA) is an abundant environmental mycotoxin with known neurotoxic potential.
  • Understanding OTA's impact on complex brain cell interactions is crucial for assessing neurological risks.

Purpose of the Study:

  • To investigate the neurotoxic effects of Ochratoxin A (OTA) on a histotypic 3D rat brain cell culture model.
  • To assess the potential of sonic hedgehog (SHH) and metallothioneins (MTs) in mitigating OTA-induced neurotoxicity.

Main Methods:

  • Exposure of 3D rat brain cell cultures to nanomolar concentrations of OTA.
  • Analysis of gene and protein expression, cell morphology, and inflammatory markers post-exposure.
  • Evaluation of co-treatment effects with SHH and MTs.

Main Results:

  • OTA exposure caused neuronal cytoskeleton disruption, demyelination, and astrocyte disturbances.
  • Repeated OTA administration led to significant neuroinflammation, including microglial activation and pro-inflammatory cytokine release.
  • Co-treatment with SHH and MTs demonstrated partial recovery of neuronal and glial cells from OTA toxicity.

Conclusions:

  • OTA exposure triggers a cascade of neurotoxic events, including demyelination and neuroinflammation.
  • The Shh-signalling pathway and astrocytic metallothioneins appear to be involved in OTA's neurotoxic mechanism.
  • SHH and MTs show promise in partially ameliorating OTA-induced neuroinflammation and cellular damage.

Related Concept Videos